Douglas Hirsch Acquires 4,642 GoodRx Shares via Deferred Stock Units

Douglas Joseph Hirsch, a director of GoodRx Holdings, Inc., acquired 4,642 shares of Class A Common Stock through deferred stock units on May 27, 2026. The acquisition was made at $0 per share as part of a deferred compensation plan. The deferred stock units will vest gradually, with 2% vesting on May 31, 2026, and the remaining 98% vesting in substantially equal monthly installments over the following 7 months, contingent on continued service. The units will settle on the earliest of December 31, 2029, separation from service, change in control, death, or disability. Following this transaction, Hirsch directly owns 247,502 shares. Additionally, he has indirect ownership through various grantor retained annuity trusts (GRATs) totaling over 5 million shares, though he disclaims beneficial ownership of shares held by trusts where his spouse serves as trustee.